ES2034326T3 - Composicion espermicida. - Google Patents

Composicion espermicida.

Info

Publication number
ES2034326T3
ES2034326T3 ES198888402358T ES88402358T ES2034326T3 ES 2034326 T3 ES2034326 T3 ES 2034326T3 ES 198888402358 T ES198888402358 T ES 198888402358T ES 88402358 T ES88402358 T ES 88402358T ES 2034326 T3 ES2034326 T3 ES 2034326T3
Authority
ES
Spain
Prior art keywords
composition
product
ionisable
ionic
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888402358T
Other languages
English (en)
Inventor
Pierre Bourbon
Pierre Lagny
Pierre Billot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atlantic Pharmaceutical Products Ltd
Original Assignee
Atlantic Pharmaceutical Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atlantic Pharmaceutical Products Ltd filed Critical Atlantic Pharmaceutical Products Ltd
Application granted granted Critical
Publication of ES2034326T3 publication Critical patent/ES2034326T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/10—Fluorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Environmental Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

LA INVENCION SE REFIERE A UNA SUSTANCIA INHIBIDORA O DESTRUCTORA DE AL MNENOS UN SER VIVIENTE UNICELULAR CON UN PROTOZAIRO, MICROBIO, BACTERIA GAMETO, HONGO, LEVADURA U OTRA CARACTERISTICA EN QUE COMPRENDA A LA VEZ FLUOR EN ESTADO IONICO O IONIZABLE Y LITIO EN ESTADO IONICO O IONIZABLE. LA INVENCION SE REFIERE IGUALMENTE A UNA COMPOSICION FARMACEUTICA, UNA COMPOSICION COSMETICA, UN PRODUCTO BACTERICIDA, ANTIBIOTICO, DESINFECTANTE, VIRUCIDA, UNA COMPOSICION ESPERMICIDA, UN PRODUCTO CONTRACEPTIVO LOCAL, UN PRODUCTO ANTIBIOTICO CON UNA SUSTANCIA DE LA INVENCION.
ES198888402358T 1987-09-22 1988-09-19 Composicion espermicida. Expired - Lifetime ES2034326T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8713086A FR2620620B1 (fr) 1987-09-22 1987-09-22 Substance inhibitrice ou destructrice d'au moins un etre vivant unicellulaire renfermant du fluor f- et du lithium li+

Publications (1)

Publication Number Publication Date
ES2034326T3 true ES2034326T3 (es) 1993-04-01

Family

ID=9355110

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888402358T Expired - Lifetime ES2034326T3 (es) 1987-09-22 1988-09-19 Composicion espermicida.

Country Status (11)

Country Link
US (1) US5063064A (es)
EP (1) EP0310476B1 (es)
JP (1) JP2777148B2 (es)
AT (1) ATE72983T1 (es)
CA (1) CA1341359C (es)
DE (1) DE3868821D1 (es)
ES (1) ES2034326T3 (es)
FR (1) FR2620620B1 (es)
GR (1) GR3004840T3 (es)
IL (1) IL87828A0 (es)
MC (1) MC1977A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2164018A1 (es) * 2000-05-26 2002-02-01 Inst De Salud Carlos Iii Empleo de una sal de litio en la elaboracion de un medicamento para el tratamiento de la infeccion causada por el virus respiratorio sincitial humano (vrdh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662941A (en) * 1987-09-22 1997-09-02 Bourbon; Pierre Method for treating diseases caused by bacterial microorganisms with a composition containing fluorine F- and lithium LI+
JPH01135704A (ja) * 1987-11-18 1989-05-29 Medical Res Internatl Ltd 微生物を破壊する表面処理方法
GB2311222A (en) * 1996-03-18 1997-09-24 Mary Viktoria Kelemen Cold sterilant composition comprising an aqueous solution of lithium iodide and iodine
WO1999027361A1 (en) * 1997-11-20 1999-06-03 Esa, Inc. Electrochemical analysis system
AU3367799A (en) 1998-03-30 1999-10-18 Esa Inc. Methodology for predicting and/or diagnosing disease
EP2359690A1 (fr) 2010-02-23 2011-08-24 East Coast Pharmaceutical Research LLC Multiplication de l'efficacité des agents anti-infectieux par une composition comprenant conjointement un agent dispersant et un agent activateur métallique
EP2982247A1 (en) * 2014-08-07 2016-02-10 Omya International AG Antiseptic product, process for preparing same and its use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097590A (en) * 1975-07-24 1978-06-27 Geraldine Fay Weisz Methods and compositions for treatment of bacterial and fungus infections of the skin
US4321277A (en) * 1978-12-04 1982-03-23 Research Lab Products, Inc. Germicidal use of compositions containing certain quaternary ammonium compounds
JPS57131714A (en) * 1980-12-24 1982-08-14 Warner Lambert Co Caries controlling method and composition
US4473547A (en) * 1982-11-18 1984-09-25 Johnson & Johnson Products Inc. Anticaries compositions
US4568540A (en) * 1984-04-18 1986-02-04 Johnson & Johnson Oral hygiene compositions
DE3543801A1 (de) * 1985-12-12 1987-06-25 Marquardt Bernd Pharmazeutisches produkt enthaltend ein gemisch aus benzoesaeure, phenol und ein alkalifluorid in waessriger oder waessrig-alkoholischer loesung und seine verwendung
ATE64854T1 (de) * 1986-05-22 1991-07-15 Atlantic Pharma Prod Zusammensetzung mit hemmender wirkung auf zumindest ein einzelliges lebewesen und/oder virus, herstellungsverfahren und anwendungen dieser zusammensetzung.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2164018A1 (es) * 2000-05-26 2002-02-01 Inst De Salud Carlos Iii Empleo de una sal de litio en la elaboracion de un medicamento para el tratamiento de la infeccion causada por el virus respiratorio sincitial humano (vrdh)

Also Published As

Publication number Publication date
JPH01163126A (ja) 1989-06-27
GR3004840T3 (es) 1993-04-28
EP0310476B1 (fr) 1992-03-04
EP0310476A1 (fr) 1989-04-05
FR2620620B1 (fr) 1991-04-05
US5063064A (en) 1991-11-05
CA1341359C (fr) 2002-05-21
DE3868821D1 (de) 1992-04-09
ATE72983T1 (de) 1992-03-15
MC1977A1 (fr) 1989-11-23
FR2620620A1 (fr) 1989-03-24
JP2777148B2 (ja) 1998-07-16
IL87828A0 (en) 1989-03-31

Similar Documents

Publication Publication Date Title
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
EP1452172A3 (en) Multiple unit pharmaceutical preparation
AU6279996A (en) Methods of delivering materials into the skin, and compositions used therein
CA2033725A1 (en) Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
HU9503842D0 (en) Stabilized pharmaceutical peptide compositions
GR3006177T3 (es)
ZA885192B (en) Pharmaceutical preparations
NO178768C (no) 11-aryl-4-östrener og antikonsepsjonsmidler inneholdende disse
ATE279112T1 (de) Verwendung von mikrobiziden und spermiziden zusammensetzungen zur inaktivierung von nicht- umhüllten viren
AU5938398A (en) Pour-on formulations containing polymeric material, glycols and glycerides
ES2034326T3 (es) Composicion espermicida.
SE8404065D0 (sv) Novel biologically active compounds
MY100936A (en) Pesticidal compositions and process for preparation thereof
AU1642888A (en) Disinfecting and sterilizing composition
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
AU7125991A (en) Novel antiulcer substance
DE69624343T2 (de) Pharmazeutische zusammensetzungen, welche ein benzydamin oder deren salz und einen antimikrobiellen wirkstoff enthalten
BR9808956A (pt) Composição pesticida
EP0373771A3 (en) New pharmaceutical uses for cystatins
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
IL106289A0 (en) Phospholipid derivatives, their preparation and pharmaceutical compositions containing them
AU8168294A (en) Solid insecticidal formulation
IL72589A0 (en) Immunomodulating medicaments of biological origin,their preparation and pharmaceutical compositions containing them
AU7533394A (en) Antiacid pharmaceutical composition in the form of a suspension based on sucralphate gel

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 310476

Country of ref document: ES